Arcadia Biosciences Inc Q1 2025 Earnings Call Transcript - Thomson StreetEvents

Arcadia Biosciences Inc Q1 2025 Earnings Call Transcript

Arcadia Biosciences Inc Q1 2025 Earnings Call Transcript - Thomson StreetEvents
Arcadia Biosciences Inc Q1 2025 Earnings Call Transcript
Published May 08, 2025
7 pages (4081 words) — Published May 08, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of RKDA.OQ earnings conference call or presentation 8-May-25 6:00pm GMT

  
Brief Excerpt:

...Operator Hello, and welcome to Arcadia Biosciences first-quarter 2025 financial results and business highlights conference call. (Operator instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to Mark Kawakami, Chief Financial Officer at Arcadia. Please go ahead. Mark Kawakami ...

  
Report Type:

Transcript

Source:
Company:
Arcadia Biosciences Inc
Ticker
RKDA.OQ
Time
6:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Benjamin Klieve - Lake Street Capital Markets - Analyst : All right, thanks for taking my questions and congratulations on another good quarter here with the momentum continuing in Zola. First, a couple of questions related to Zola. T.J., you talked about kind of the momentum continuing and expanding your distribution pipeline. You noted that


Question: Benjamin Klieve - Lake Street Capital Markets - Analyst : Okay. Very good. And then regarding some new accounts and new distribution, the -- historically, there have been kind of a modest lag before those successes really hit the income statement. Do you expect that to -- the momentum that you have here to be reflected still in the 2025 financials? Or is that going to be more of a '26 type event?


Question: Benjamin Klieve - Lake Street Capital Markets - Analyst : Okay. That's great. Very good. One question regarding the kind of legacy ag biotech business. That one remaining patent that you have. Do you guys anticipate that there's any commercial value there? Or is it similar to the patent that you just got back from Bioceres that you simply just want to get it back so you can retire it?


Question: Benjamin Klieve - Lake Street Capital Markets - Analyst : Got it. Okay. Very helpful. And then last one for me, and I'll get back in queue. The -- Mark, you noted $2.5 million initial payment for the note receivable. I just want to confirm, do you expect to have that in hand here within this -- within the second quarter? Or is that something that could get pushed out into the third? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. MAY 08, 2025 / 6:00PM, RKDA.OQ - Q1 2025 Arcadia Biosciences Inc Earnings Call


Question: Benjamin Klieve - Lake Street Capital Markets - Analyst : Okay. Very good. All right, well I appreciate you guys taking my questions. Congratulations again and I'll get back in queue.

Table Of Contents

Arcadia Biosciences Inc Annual Shareholders Meeting Transcript – 2025-12-19 – US$ 54.00 – Edited Transcript of RKDA.OQ shareholder or annual meeting 19-Dec-25 7:00pm GMT

Arcadia Biosciences Inc Q4 2024 Earnings Call Transcript – 2025-03-20 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 20-Mar-25 8:30pm GMT

Arcadia Biosciences Inc To Discuss Key Details And Benefits of The Transaction -M&A Call Transcript – 2024-12-11 – US$ 54.00 – Edited Transcript of RKDA.OQ M&A conference call or presentation 11-Dec-24 9:30pm GMT

Arcadia Biosciences Inc Q3 2024 Earnings Call Transcript – 2024-11-12 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 12-Nov-24 9:30pm GMT

Arcadia Biosciences Inc Q2 2024 Earnings Call Transcript – 2024-08-13 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 13-Aug-24 8:30pm GMT

Arcadia Biosciences Inc Annual Shareholders Meeting Transcript – 2024-06-25 – US$ 54.00 – Edited Transcript of RKDA.OQ shareholder or annual meeting 25-Jun-24 6:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Arcadia Biosciences Inc Q1 2025 Earnings Call Transcript" May 08, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2025-Arcadia-Biosciences-Inc-Earnings-Call-T16345702>
  
APA:
Thomson StreetEvents. (2025). Arcadia Biosciences Inc Q1 2025 Earnings Call Transcript May 08, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2025-Arcadia-Biosciences-Inc-Earnings-Call-T16345702>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.